Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia
Clinical trial NCT04885218 · COMPLETED
Trial details
- NCT number
- NCT04885218
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2023-05-23
- Enrollment
- 692
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.